Lmito Therapeutics Co.,Ltd.

  • Biotech or pharma, therapeutic R&D

Lmito, a JLABS Korea portfolio company, is an innovation-driven biotechnology company dedicated to developing novel and effective therapies for autoimmune/ neuroinflammatory diseases and fibrosis through the emerging concept of 'metabolic reprogramming' within diverse microenvironments. (IBD, RA, IPF, CMT1A, ALS).  

Address

South Korea

Website

https://www.lmito.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS